ReleaseWire

Global Markets Direct's, 'Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2014', provides an overview of the Gastroesophageal (GE) Junction Carcinomas's therapeutic pipeline.

Global Markets Direct's, 'Flexion Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Flexion Therapeutics, Inc.'s pharmaceutical research and development focus.

GlobalData's clinical trial report, "Cerebral Vasospasm Global Clinical Trials Review, H1, 2014" provides data on the Cerebral Vasospasm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral Vasospasm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cerebral Vasospasm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'AstraZeneca PLC - Product Pipeline Review - 2014', provides an overview of the AstraZeneca PLC's pharmaceutical research and development focus.

Global Markets Direct's, 'Shigella Infections (Shigellosis) - Pipeline Review, H1 2014', provides an overview of the Shigella Infections (Shigellosis)'s therapeutic pipeline.

Global Markets Direct's, 'Restenosis - Pipeline Review, H1 2014', provides an overview of the Restenosis's therapeutic pipeline.

GlobalData's clinical trial report, "Restless Legs Syndrome Global Clinical Trials Review, H1, 2014" provides data on the Restless Legs Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Restless Legs Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Restless Legs Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Stemline Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Stemline Therapeutics, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Zalicus Inc. - Product Pipeline Review - 2014', provides an overview of the Zalicus Inc.'s pharmaceutical research and development focus.

GlobalData's clinical trial report, "Drug Addiction Global Clinical Trials Review, H1, 2014" provides data on the Drug Addiction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Drug Addiction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Drug Addiction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Dongkook Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Dongkook Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

GlobalData's clinical trial report, "Batten Disease Global Clinical Trials Review, H1, 2014" provides data on the Batten Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Batten Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Batten Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Degenerative Spondylolisthesis Global Clinical Trials Review, H1, 2014" provides data on the Degenerative Spondylolisthesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Degenerative Spondylolisthesis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Degenerative Spondylolisthesis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Neurocrine Biosciences, Inc. - Product Pipeline Review - 2014', provides an overview of the Neurocrine Biosciences, Inc.'s pharmaceutical research and development focus.

MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Global Markets Direct's, 'ActogeniX NV - Product Pipeline Review - 2014', provides an overview of the ActogeniX NV's pharmaceutical research and development focus.

Global Markets Direct's, 'Viventia Biotechnologies Inc. - Product Pipeline Review - 2014', provides an overview of the Viventia Biotechnologies Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H1 2014', provides an overview of the Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome)'s therapeutic pipeline.

Global Markets Direct's, 'Reperfusion Injury - Pipeline Review, H1 2014', provides an overview of the Reperfusion Injury's therapeutic pipeline.

Global Markets Direct's, 'Teva Pharmaceutical Industries Limited - Product Pipeline Review - 2014', provides an overview of the Teva Pharmaceutical Industries Limited's pharmaceutical research and development focus.

CEL-SCI Corporation announced that during the month of June the Company enrolled 19 patients with advanced primary, not yet treated, head and neck cancer into its global pivotal Phase III head and neck cancer trial for its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection). A total of 54 patients were enrolled over the past three months, with 21 enrolled in April, 14 in May, and 19 in June. This marks a 93% increase over the prior three month period when a total of 28 patients were enrolled, with 8 in January, 6 in February, and 14 in March. Since the beginning of 2014, the Company has enrolled a total of 82 patients. This compares with 10 patients enrolled in the first half of 2013.

Combining ingredients for efficiency, convenience and greater benefits has been a common practice for centuries. An increase in the number of consumers seeking non-prescription pain relief for arthritis has intensified the search for the best natural ingredients for combination products.

Neuroprotective products are used in protecting the brain neurons from injury or degeneration. They are extremely helpful in treatment of several CNS disorders such as Alzheimer's disease, traumatic brain injuries and Parkinson's disease. Since the risk of Neurodegenerative diseases increases with age, Neurodegenerative diseases are common among the aged population. Further, with a rise in the life span of the population, there is greater scope for the Neuroprotective products market. Increasing incidences of brain injuries due to road accidents are also driving the market growth. However, strict government regulations, high rate of failure of the drugs in the clinical trials and requirement of high investment would impede the market growth.

Global Markets Direct's, 'Pompe Disease - Pipeline Review, H1 2014', provides an overview of the Pompe Disease's therapeutic pipeline.

GlobalData's clinical trial report, "Paralysis Global Clinical Trials Review, H1, 2014" provides data on the Paralysis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Paralysis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Paralysis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.